Many diseases share the same symptoms, causing people to get confused and either undermine or overwhelm themselves with worries. With the current flu season on the rise, people in the United States are being very careful about their health and are taking necessary precautions to make sure they do not catch any more respiratory illnesses. Often these diseases show symptoms like coughing and wheezing, nothing that warrants anything more than a general doctor’s visit, sometimes people even think it it is a simple cold, but it could be something worse!
The Centers For Disease Control and Prevention (CDC) report on 28 February, last Friday on Respiratory Virus Activity Levels reported a moderate number of people are seeking medical help for respiratory illnesses. The flu is sending many people to the emergency room, RSV Respiratory syncytial virus has been sending many people to the ER along with COVID-19.
While flu test results are slightly less positive than last week, COVID-19 and RSV test results are about the same. In our community's wastewater, the flu virus is still very high, COVID-19 is moderate, and RSV is low. Looking forward, we expect COVID-19 emergency room visits to stay low. While flu visits are still high, they should start to go down soon.
So, even though it might feel like winter is ending, these viruses are still active, and we need to be careful. They are not going away quickly and can still spread easily. Here are some symptoms that should be treated with urgency right now.
When you're really sick, you might not feel like eating or drinking. This can lead to dehydration, which is when your body doesn't have enough water. If your pee is dark yellow, or you feel dizzy, you might be dehydrated. If you pass out, get confused, or your heart beats really fast, you need to go to the hospital right away. Healthcare professionals can give you fluids through a needle to help you feel better. Being dehydrated is very dangerous, and it is important to take it seriously.
If you're having trouble breathing, or if you're breathing really fast, that's a big sign. It could mean that you have pneumonia or that your body isn't getting enough oxygen. Shortness of breath is always a reason to go to the emergency room. Your body is telling you that something is seriously wrong. It is very important to seek help right away. Do not wait it out at home.
If your lips or fingers start to turn blue, that means you're not getting enough oxygen. Also, if you're so tired that you can barely get out of bed, that's another sign that you need to go to the hospital. These are serious symptoms that mean your body needs help right away.
Some people are more likely to get very sick from these viruses. Pregnant people, little kids, and older adults are at higher risk. Also, people who have health problems like heart or lung disease, or people with weak immune systems, are more likely to have serious problems. Older adults are often hospitalized with the flu, COVID, and RSV. These groups need to be extra careful to avoid getting sick. It is very important that these groups get vaccinated.
RSV is especially dangerous for babies and young children. It's one of the main reasons why young kids end up in the hospital. This virus can make it very hard for them to breathe. It is very important to protect young children from this virus, especially in the first few years of their lives.
Credit: AI
Novo Nordisk’s GLP-1 weight loss pill, Wegovy, has been approved in Australia for sale. An alternative to weekly weight loss injections, the Therapeutic Goods Administration (TGA) has cleared Wegovy, which contains semaglutide, the same active ingredient found in GLP-1 weight loss injections: Wegovy and Ozempic.
The pill received TGA approval on November 3, 2026, expecting to reach the shelves by Christmas.
It is prescribed to eligible adults to help manage chronic obesity along with lifestyle changes. It is also approved to reduce the risk of major cardiovascular events in eligible patients.
Until now, Australians seeking GLP-1 medication for weight management have primarily had access to injectable formulations. The tablet offers a different approach.
Also read: Eli Lilly Can Continue Zepbound Ads Despite Novo Nordisk’s Claims Over Weight-Loss Drug Comparisons
The new tablet contains semaglutide, a GLP-1 receptor agonist that mimics the action of the naturally occurring glucagon-like peptide-1 hormone.
GLP-1 medications act on appetite regulation. They help users feel full, reduce cravings and slow stomach emptying, which can lead to lower calorie intake and weight loss.
Unlike injectable Wegovy, which is administered once a week, this tablet should be taken every day.
The TGA has approved four tablet strengths for sale: 1.5 mg, 4 mg, 9 mg and 25 mg. Treatment starts at a lower dose, which is gradually increased over approximately 16 weeks under medical supervision. The tablet also has specific use requirements. Patients must:
The fasting instructions are important because semaglutide is absorbed less efficiently when taken orally. So following that instruction is crucial as a 25 mg tablet has to achieve an effect comparable to the 2.4 mg weekly injectable Wegovy dose.
The TGA approval covers adults who meet specific weight-related criteria. These include:
These conditions may include high blood pressure, abnormal cholesterol levels, type 2 diabetes, fatty liver disease or other weight-related complications.
The medication is also approved to reduce the risk of major adverse cardiovascular events in eligible adults with cardiovascular disease and those who are overweight or obese but don’t have diabetes.
However, approval does not mean everyone meeting these criteria should automatically take the medication. A doctor must assess your health, medical history, and risks before prescribing it.
Dr Brendan Hanrahan, an obesity medicine specialist at Brisbane's Wesley Hospital, welcomed wider access to the medication, saying GLP-1 drugs have "lived up to and exceeded the hype". However, he questioned whether BMI alone is enough to determine eligibility.
He suggested waist circumference could offer some information about health risks, saying that some people may experience complications related to weight even when their BMI falls within the ‘normal’ healthy range.
The oral pill does not eliminate the side effects associated with semaglutide. Common adverse effects include:
Gastrointestinal symptoms can sometimes lead to dehydration, which may increase the risk of kidney problems.
The TGA also warns about more serious complications, including acute pancreatitis and diabetic retinopathy. People with diabetes, particularly those with pre-existing eye disease, may need clinical monitoring.
Semaglutide is not recommended during pregnancy, and people planning to become pregnant should discuss treatment and timing with their doctor.
The TGA has also warned of depression and suicidal thoughts or behaviours linked with GLP-1 medications.
Credit: AI
A breast cancer diagnosis can change more than a woman’s immediate health priorities. Suddenly, appointments, treatment decisions and medical advice become part of everyday life, alongside work deadlines, family responsibilities, relationships and personal plans. Even as women focus on getting better, questions about how treatment might affect their routines, independence and future can be difficult to navigate.
For women diagnosed with early breast cancer, treatment offers an opportunity to address the disease and reduce the risk of it returning. But the experience is about more than medical outcomes alone. How women feel during treatment, the support available to them and their ability to continue doing the things that matter to them are also important considerations.
Treating early breast cancer involves looking beyond the immediate diagnosis to understand what matters to each patient. While our priority is to recommend treatment that offers the best possible clinical benefit, it is equally important to discuss how treatment may affect everyday life, from managing side effects to maintaining relationships and planning for the future. By encouraging open conversations about advanced therapies and addressing patients’ concerns early, we can help women make informed decisions while supporting their quality of life throughout the treatment journey.
Here are four ways women can approach treatment while keeping their personal well-being in focus.
Breast cancer treatment can affect everyday life in different ways, from recovery after surgery to managing side effects or making time for regular appointments. For women balancing work, family responsibilities and personal commitments, understanding what treatment involves can help them plan ahead and arrange the support they need.
Advances in breast cancer care have expanded treatment options for eligible patients, with some targeted therapies offering a more tailored approach that may help reduce certain treatment-related side effects. Understanding the potential benefits and impact of each option on quality of life can help women make informed decisions with their oncologist. Discussing how treatment may affect daily routines, energy levels and recovery can also help women plan for the journey ahead while continuing to prioritise what matters to them.
Breast cancer treatment affects every woman differently. Depending on the therapy, side effects may include fatigue, nausea, joint pain, sleep disturbances or changes in hair and weight, potentially making everyday activities more challenging.
Women should discuss potential side effects with their healthcare team and seek advice early on, as appropriate interventions can help manage symptoms. Gentle physical activity, a balanced diet and adequate rest may also support overall well-being, depending on individual needs and medical advice. The goal is to find a manageable routine that supports recovery and quality of life without putting every other aspect of life on hold.
The emotional impact of breast cancer can be as significant as the physical effects. Uncertainty about the future, changes in body image and concerns about loved ones can affect emotional well-being. Talking to trusted friends, joining a support group or seeking professional guidance can help women navigate these challenges, while open conversations with family can make it easier to ask for support.
Personal concerns, including fertility, intimacy and sexual health, also deserve attention. Women should discuss these with their healthcare team before treatment begins, particularly when fertility preservation may be an option. Addressing these concerns early can help women understand their choices and ensure their emotional well-being and personal priorities remain part of the treatment journey.
Looking beyond initial treatment can help women prepare for the next stages of care. Depending on the cancer’s characteristics, doctors may recommend additional treatment to reduce recurrence risk, with some women continuing medication for several years. Understanding the purpose, expected benefits and duration of treatment can help women plan ahead.
Regular follow-up appointments remain important for monitoring recovery and addressing new symptoms or ongoing side effects. If treatment becomes difficult to manage, women should speak to their healthcare team, who may suggest ways to manage symptoms or explore suitable alternatives. Staying informed about the care plan can help women look ahead with greater confidence while prioritising their long-term health and quality of life.
An early breast cancer diagnosis can bring uncertainty, but it does not erase the other parts of a woman’s life. Work, relationships, family, personal ambitions and everyday pleasures remain important, even while treatment becomes a priority.
Making space for these aspects of life starts with asking questions, communicating concerns and seeking support before challenges become overwhelming. Clinical outcomes and recurrence risk remain important considerations, but so does the experience of living through treatment.
The goal is not to manage every aspect of the journey perfectly. It is to ensure that women have the information, care and support they need to navigate treatment in a way that considers both their health and their quality of life.
By Dr. Sachin Sekhar Biswal, Consultant Medical Oncologist, Manipal Hospital, Bhubaneswar
Credit: AI
Living in cities could mean your home may be located near a busy road, railway line or airport. It also means your comfort and sleep may get interrupted from time to time due to excessive noise. After living at such places for a long time, the traffic sounds may turn into white noise for you but it does not mean that you are completely safe.
A recent study says that constant exposure to transportation noise could increase your risk of cardiovascular disease, even if you sleep for seven to nine hours every night.
The research, presented at the American Heart Association's (AHA) Scientific Sessions 2026, found that adults who were exposed to higher levels of transportation noise were more likely to face cardiovascular risk factors like high cholesterol, hypertension and diabetes.
The study is based on health records of 108,051 adults, with an average age of 57 years. They also used US government data to estimate average daily transportation noise levels around the homes of participants. About one-third of participants were exposed to noise levels exceeding 50 decibels.
The study found that exposure to transportation noise above 50 decibels could lead to an 8% to 10% increase in the development of major cardiovascular risk factors. The researchers examined average 24-hour transportation noise levels above 45 to 50 decibels. These estimates included noise from road traffic, trains and aircraft.
Dr Joseph Nguyen, an internal medicine resident at Massachusetts General Hospital, emphasised that the measurements represented daily averages rather than peak noise levels. "These levels are similar to moderate rainfall or typing on a keyboard," he explained.
He added that noise levels can rise considerably during specific events. Subway stations, for example, may reach more than 100 decibels when trains arrive or depart.
In terms of individual risk factors, the strongest link was observed with high cholesterol, followed by high blood pressure and diabetes.
One of the findings that stood out in the study is that the cardiovascular risk due to transportation noise was the same among those with healthy as well as unhealthy sleep schedules.
For this study, unhealthy sleep was defined as having a diagnosed sleep disorder or regularly sleeping fewer than seven hours or more than nine hours per night.
"The key finding of our study is that the relationship between noise exposure and cardiovascular disease events, and the number of cardiovascular risk factors developed, was similar among people with and without unhealthy sleep, suggesting that healthy sleep is not protective against adverse heart impacts of noise exposure," said Dr Nguyen.
"We expected that disordered sleep would influence the relationship between noise exposure and heart disease. It was surprising to find that sleep health appeared to play no role," he added.
Also read: NCCN Issues First-Ever Guidelines For Cancer Caregivers
Experts believe that long-term exposure to transportation noise may activate the body's stress response, which could affect cardiovascular health over time.
Even when people do not wake up or feel disturbed by noise, their bodies may still unconsciously respond to these environmental sounds.
This could result in changes in stress hormones, blood pressure and other processes. Repeated exposure may contribute to cardiovascular strain over time.
Researchers suggested several ways people living in noisy neighbourhoods could reduce exposure inside their homes:
Dr Nguyen said the findings highlight the importance of reducing environmental noise through better urban planning and infrastructure for protecting long-term cardiovascular health.
© $2026 Times Horizon Private Limited